The Good Manufacturing Practice Concept

  • T. F. Zuck
Part of the Developments in Hematology and Immunology book series (DIHI, volume 29)


When The jungle was published in 1905 in the United States the general public became aware of the deplorable and filthy conditions in Chicago slaughterhouses [1]. The exposé was written as a social comment about the manner in which the industry treated its employees rather than as an indictment of the unwholesomeness of packed meats. Although deaths caused by consuming infected meat were described, Sinclair’s targets were the pitiful living conditions of the workers and their families and the greed of the packing plant owners. The book is widely credited for causing the passage of the Federal Food, Drug and Liquor Act of 1906. The key provision of this act required manufacturers to label their products accurately.


Blood Component Blood Bank Blood Center Product License Packed Meat 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sinclair U. The jungle. Cambridge, MA, Robert Bently, Inc. 1905.Google Scholar
  2. 2.
    Timm EA. 75 Years compliance with biological product regulations. Food Drug Cosmetic Law J 1978;33:225–30.Google Scholar
  3. 3.
    FDA brings injunction against prescription drug manufacturer. CCBC Newsletter. Washington, CCBC, 1993;August 20:1.Google Scholar
  4. 4.
    Polesky HF. Should blood banks institute GMPs? Continues flow. Baxter, Deerfield, IL, 1993;Jan-Feb:4,8.Google Scholar
  5. 5.
    Menitove JE. The recent emphasis on good manufacturing practices and the pharmaceutical manufacturing approach damages blood banking and transfusion medicine as medical care activities. Transfusion 1993;33:439–42.CrossRefGoogle Scholar
  6. 6.
    Laffel G, Blumenthal D. The case of using industrial quality management science in health care organizations. JAMA 1989;262:2869–73.CrossRefGoogle Scholar
  7. 7.
    Anderson K. Should blood banks institute GMPs? Continuous flow. Baxter, Deerfield, IL, 1993;Jan-Feb:8,10.Google Scholar
  8. 8.
    Kritchevsky SB, Simmons BP. Continuous quality improvement. JAMA 1991;266: 1817–23.CrossRefGoogle Scholar
  9. 9.
    Miller WV. Blood banks should use good manufacturing practices and the pharmaceutical manufacturing approach. Transfusion 1993;33:435–8.CrossRefGoogle Scholar
  10. 10.
    Deming WE. Out of the crisis. Massachusetts Institute of Technology, Center for Advanced Engineering Study, Cambridge, MA, 1986.Google Scholar
  11. 11.
    Blood manufacturers must act more like drug manufacturers. CCBC Newsletter, Washington, CCBC 1993;July 30:1.Google Scholar
  12. 12.
    Train-the-trainer manual. CCBC and Ortho Diagnostic System, Washington and Raritanl991.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1994

Authors and Affiliations

  • T. F. Zuck

There are no affiliations available

Personalised recommendations